ThesisEpidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients
ThesisEpidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAssessment of circulating levels of neutrophil adhesion molecules and factors affecting their expression in patients with chronic liver diseases
ThesisAssessment of circulating levels of neutrophil adhesion molecules and factors affecting their expression in patients with chronic liver diseases
ThesisExpression of hepatocyte paraffin 1 antibody and vascular endothelial growth factor in hepatocellular carcinoma and chronic viral hepatitis : An immunohistochemcial study
ThesisExpression of hepatocyte paraffin 1 antibody and vascular endothelial growth factor in hepatocellular carcinoma and chronic viral hepatitis : An immunohistochemcial study
ThesisThe role of glutathione -S- transferase gene mutation in the development of hepatocellular carcinoma
ThesisThe role of glutathione -S- transferase gene mutation in the development of hepatocellular carcinoma
ThesisBiological study on alpha‐L‐fucosidase insera of hepatocellular carcinoma with highand low alphafetoprotein levels
ThesisBiological study on alpha‐L‐fucosidase insera of hepatocellular carcinoma with highand low alphafetoprotein levels